Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers

The aim of the present study was to compare, in healthy human volunteers (male and female), the corneal contact time of various formulations, each containing one viscosity enhancer from the following list: a phase-transition system (gellan gum, Gelrite), a heteropolysaccharide (xanthan gum) and curr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of ocular pharmacology and therapeutics 1996, Vol.12 (4), p.481-488
Hauptverfasser: MESEGUER, G, BURT, P, PLAZONNET, B, ROZIER, A, GURNY, R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 488
container_issue 4
container_start_page 481
container_title Journal of ocular pharmacology and therapeutics
container_volume 12
creator MESEGUER, G
BURT, P
PLAZONNET, B
ROZIER, A
GURNY, R
description The aim of the present study was to compare, in healthy human volunteers (male and female), the corneal contact time of various formulations, each containing one viscosity enhancer from the following list: a phase-transition system (gellan gum, Gelrite), a heteropolysaccharide (xanthan gum) and currently used polymers hydroxyethylcellulose, hydroxypropylmethylcellulose, or poly(vinyl alcohol). These different solutions were compared to a reference solution containing no viscosity enhancers. The corneal contact time of the formulations was evaluated over more than 20 minutes by gamma scintigraphy using Technetium-99m (Tc-99m DTPA) as a radioactive label. An eyedrop containing pilocarpine salts (25 microliters) was instilled in one eye only. Each volunteer received 4 formulations, the interval between the instillations being one week. The protocol has been approved by the relevant institutional human experimentation committee. One minute after instillation, only 23% of the reference solution remained on the ocular surface, whereas the novel formulations maintained, respectively, 77% (xanthan gum) or 82% (Gelrite) of the tracer on the ocular surface. Twenty-one min after instillation, 12% (reference solution), 25% (xanthan gum solution), and 39% (gelrite solution) of the tracer remained on the ocular surface. The results confirm that an increase in viscosity of the formulation (xanthan) delays the clearance of the instilled solution by the tear flow. The effect of the gelation mechanism is superior, especially at the later time points. In this respect, xanthan gum and, particularly, Gelrite are suitable vehicles for ophthalmic drugs.
doi_str_mv 10.1089/jop.1996.12.481
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78594511</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78594511</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-331070ded3f595951b3eaeb074ec50fcd80bdbc32b39d1beb206e4f48d33b0af3</originalsourceid><addsrcrecordid>eNo9kEFr3DAQRkVoSTfbnHMK-FB68-6MZdnysSxpEgjk0tKjkORxVostuZK3sP--CruEOcww8-Y7PMbuEDYIstsewrzBrms2WG1qiVdshUK0Zdvy6lOeQULZNpJ_YTcpHQCQQ4PX7Fp2AhtZr9ifRz1NukjW-cW9RT3vnS1smGYdXQq-CENBJ-pjmFNe-0U77_xbMbsxWB1n56lwvtiTHpf9qfgXxqNfiGL6yj4Pekx0e-lr9vvnw6_dU_ny-vi8-_FSWl7hUnKO0EJPPR9ElwsNJ00G2pqsgMH2EkxvMmt416MhU0FD9VDLnnMDeuBr9v2cO8fw90hpUZNLlsZRewrHpFopulogZnB7Bm0MKUUa1BzdpONJIah3lSqrVO8qFVYqq8wf95foo5mo_-Av7vL92-Wuk9XjELW3Ln1glahaEMD_A7dpfsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78594511</pqid></control><display><type>article</type><title>Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>MESEGUER, G ; BURT, P ; PLAZONNET, B ; ROZIER, A ; GURNY, R</creator><creatorcontrib>MESEGUER, G ; BURT, P ; PLAZONNET, B ; ROZIER, A ; GURNY, R</creatorcontrib><description>The aim of the present study was to compare, in healthy human volunteers (male and female), the corneal contact time of various formulations, each containing one viscosity enhancer from the following list: a phase-transition system (gellan gum, Gelrite), a heteropolysaccharide (xanthan gum) and currently used polymers hydroxyethylcellulose, hydroxypropylmethylcellulose, or poly(vinyl alcohol). These different solutions were compared to a reference solution containing no viscosity enhancers. The corneal contact time of the formulations was evaluated over more than 20 minutes by gamma scintigraphy using Technetium-99m (Tc-99m DTPA) as a radioactive label. An eyedrop containing pilocarpine salts (25 microliters) was instilled in one eye only. Each volunteer received 4 formulations, the interval between the instillations being one week. The protocol has been approved by the relevant institutional human experimentation committee. One minute after instillation, only 23% of the reference solution remained on the ocular surface, whereas the novel formulations maintained, respectively, 77% (xanthan gum) or 82% (Gelrite) of the tracer on the ocular surface. Twenty-one min after instillation, 12% (reference solution), 25% (xanthan gum solution), and 39% (gelrite solution) of the tracer remained on the ocular surface. The results confirm that an increase in viscosity of the formulation (xanthan) delays the clearance of the instilled solution by the tear flow. The effect of the gelation mechanism is superior, especially at the later time points. In this respect, xanthan gum and, particularly, Gelrite are suitable vehicles for ophthalmic drugs.</description><identifier>ISSN: 1080-7683</identifier><identifier>EISSN: 1557-7732</identifier><identifier>DOI: 10.1089/jop.1996.12.481</identifier><identifier>PMID: 8951684</identifier><language>eng</language><publisher>Larchmont, NY: Liebert</publisher><subject>Biological and medical sciences ; Biological Availability ; Cornea - diagnostic imaging ; Cornea - metabolism ; Drug Carriers ; Eye ; Female ; Gels ; General pharmacology ; Humans ; Male ; Medical sciences ; Muscarinic Agonists - pharmacokinetics ; Ophthalmic Solutions - pharmacokinetics ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Pilocarpine - pharmacokinetics ; Polymers ; Polysaccharides, Bacterial ; Radionuclide Imaging ; Radiopharmaceuticals - pharmacokinetics ; Technetium Tc 99m Pentetate - pharmacokinetics ; Viscosity</subject><ispartof>Journal of ocular pharmacology and therapeutics, 1996, Vol.12 (4), p.481-488</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c321t-331070ded3f595951b3eaeb074ec50fcd80bdbc32b39d1beb206e4f48d33b0af3</citedby><cites>FETCH-LOGICAL-c321t-331070ded3f595951b3eaeb074ec50fcd80bdbc32b39d1beb206e4f48d33b0af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3042,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2527050$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8951684$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MESEGUER, G</creatorcontrib><creatorcontrib>BURT, P</creatorcontrib><creatorcontrib>PLAZONNET, B</creatorcontrib><creatorcontrib>ROZIER, A</creatorcontrib><creatorcontrib>GURNY, R</creatorcontrib><title>Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers</title><title>Journal of ocular pharmacology and therapeutics</title><addtitle>J Ocul Pharmacol Ther</addtitle><description>The aim of the present study was to compare, in healthy human volunteers (male and female), the corneal contact time of various formulations, each containing one viscosity enhancer from the following list: a phase-transition system (gellan gum, Gelrite), a heteropolysaccharide (xanthan gum) and currently used polymers hydroxyethylcellulose, hydroxypropylmethylcellulose, or poly(vinyl alcohol). These different solutions were compared to a reference solution containing no viscosity enhancers. The corneal contact time of the formulations was evaluated over more than 20 minutes by gamma scintigraphy using Technetium-99m (Tc-99m DTPA) as a radioactive label. An eyedrop containing pilocarpine salts (25 microliters) was instilled in one eye only. Each volunteer received 4 formulations, the interval between the instillations being one week. The protocol has been approved by the relevant institutional human experimentation committee. One minute after instillation, only 23% of the reference solution remained on the ocular surface, whereas the novel formulations maintained, respectively, 77% (xanthan gum) or 82% (Gelrite) of the tracer on the ocular surface. Twenty-one min after instillation, 12% (reference solution), 25% (xanthan gum solution), and 39% (gelrite solution) of the tracer remained on the ocular surface. The results confirm that an increase in viscosity of the formulation (xanthan) delays the clearance of the instilled solution by the tear flow. The effect of the gelation mechanism is superior, especially at the later time points. In this respect, xanthan gum and, particularly, Gelrite are suitable vehicles for ophthalmic drugs.</description><subject>Biological and medical sciences</subject><subject>Biological Availability</subject><subject>Cornea - diagnostic imaging</subject><subject>Cornea - metabolism</subject><subject>Drug Carriers</subject><subject>Eye</subject><subject>Female</subject><subject>Gels</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscarinic Agonists - pharmacokinetics</subject><subject>Ophthalmic Solutions - pharmacokinetics</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Pilocarpine - pharmacokinetics</subject><subject>Polymers</subject><subject>Polysaccharides, Bacterial</subject><subject>Radionuclide Imaging</subject><subject>Radiopharmaceuticals - pharmacokinetics</subject><subject>Technetium Tc 99m Pentetate - pharmacokinetics</subject><subject>Viscosity</subject><issn>1080-7683</issn><issn>1557-7732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEFr3DAQRkVoSTfbnHMK-FB68-6MZdnysSxpEgjk0tKjkORxVostuZK3sP--CruEOcww8-Y7PMbuEDYIstsewrzBrms2WG1qiVdshUK0Zdvy6lOeQULZNpJ_YTcpHQCQQ4PX7Fp2AhtZr9ifRz1NukjW-cW9RT3vnS1smGYdXQq-CENBJ-pjmFNe-0U77_xbMbsxWB1n56lwvtiTHpf9qfgXxqNfiGL6yj4Pekx0e-lr9vvnw6_dU_ny-vi8-_FSWl7hUnKO0EJPPR9ElwsNJ00G2pqsgMH2EkxvMmt416MhU0FD9VDLnnMDeuBr9v2cO8fw90hpUZNLlsZRewrHpFopulogZnB7Bm0MKUUa1BzdpONJIah3lSqrVO8qFVYqq8wf95foo5mo_-Av7vL92-Wuk9XjELW3Ln1glahaEMD_A7dpfsg</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>MESEGUER, G</creator><creator>BURT, P</creator><creator>PLAZONNET, B</creator><creator>ROZIER, A</creator><creator>GURNY, R</creator><general>Liebert</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1996</creationdate><title>Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers</title><author>MESEGUER, G ; BURT, P ; PLAZONNET, B ; ROZIER, A ; GURNY, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-331070ded3f595951b3eaeb074ec50fcd80bdbc32b39d1beb206e4f48d33b0af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Biological Availability</topic><topic>Cornea - diagnostic imaging</topic><topic>Cornea - metabolism</topic><topic>Drug Carriers</topic><topic>Eye</topic><topic>Female</topic><topic>Gels</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscarinic Agonists - pharmacokinetics</topic><topic>Ophthalmic Solutions - pharmacokinetics</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Pilocarpine - pharmacokinetics</topic><topic>Polymers</topic><topic>Polysaccharides, Bacterial</topic><topic>Radionuclide Imaging</topic><topic>Radiopharmaceuticals - pharmacokinetics</topic><topic>Technetium Tc 99m Pentetate - pharmacokinetics</topic><topic>Viscosity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MESEGUER, G</creatorcontrib><creatorcontrib>BURT, P</creatorcontrib><creatorcontrib>PLAZONNET, B</creatorcontrib><creatorcontrib>ROZIER, A</creatorcontrib><creatorcontrib>GURNY, R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of ocular pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MESEGUER, G</au><au>BURT, P</au><au>PLAZONNET, B</au><au>ROZIER, A</au><au>GURNY, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers</atitle><jtitle>Journal of ocular pharmacology and therapeutics</jtitle><addtitle>J Ocul Pharmacol Ther</addtitle><date>1996</date><risdate>1996</risdate><volume>12</volume><issue>4</issue><spage>481</spage><epage>488</epage><pages>481-488</pages><issn>1080-7683</issn><eissn>1557-7732</eissn><abstract>The aim of the present study was to compare, in healthy human volunteers (male and female), the corneal contact time of various formulations, each containing one viscosity enhancer from the following list: a phase-transition system (gellan gum, Gelrite), a heteropolysaccharide (xanthan gum) and currently used polymers hydroxyethylcellulose, hydroxypropylmethylcellulose, or poly(vinyl alcohol). These different solutions were compared to a reference solution containing no viscosity enhancers. The corneal contact time of the formulations was evaluated over more than 20 minutes by gamma scintigraphy using Technetium-99m (Tc-99m DTPA) as a radioactive label. An eyedrop containing pilocarpine salts (25 microliters) was instilled in one eye only. Each volunteer received 4 formulations, the interval between the instillations being one week. The protocol has been approved by the relevant institutional human experimentation committee. One minute after instillation, only 23% of the reference solution remained on the ocular surface, whereas the novel formulations maintained, respectively, 77% (xanthan gum) or 82% (Gelrite) of the tracer on the ocular surface. Twenty-one min after instillation, 12% (reference solution), 25% (xanthan gum solution), and 39% (gelrite solution) of the tracer remained on the ocular surface. The results confirm that an increase in viscosity of the formulation (xanthan) delays the clearance of the instilled solution by the tear flow. The effect of the gelation mechanism is superior, especially at the later time points. In this respect, xanthan gum and, particularly, Gelrite are suitable vehicles for ophthalmic drugs.</abstract><cop>Larchmont, NY</cop><pub>Liebert</pub><pmid>8951684</pmid><doi>10.1089/jop.1996.12.481</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1080-7683
ispartof Journal of ocular pharmacology and therapeutics, 1996, Vol.12 (4), p.481-488
issn 1080-7683
1557-7732
language eng
recordid cdi_proquest_miscellaneous_78594511
source Mary Ann Liebert Online Subscription; MEDLINE
subjects Biological and medical sciences
Biological Availability
Cornea - diagnostic imaging
Cornea - metabolism
Drug Carriers
Eye
Female
Gels
General pharmacology
Humans
Male
Medical sciences
Muscarinic Agonists - pharmacokinetics
Ophthalmic Solutions - pharmacokinetics
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Pilocarpine - pharmacokinetics
Polymers
Polysaccharides, Bacterial
Radionuclide Imaging
Radiopharmaceuticals - pharmacokinetics
Technetium Tc 99m Pentetate - pharmacokinetics
Viscosity
title Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A38%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gamma%20scintigraphic%20comparison%20of%20eyedrops%20containing%20pilocarpine%20in%20healthy%20volunteers&rft.jtitle=Journal%20of%20ocular%20pharmacology%20and%20therapeutics&rft.au=MESEGUER,%20G&rft.date=1996&rft.volume=12&rft.issue=4&rft.spage=481&rft.epage=488&rft.pages=481-488&rft.issn=1080-7683&rft.eissn=1557-7732&rft_id=info:doi/10.1089/jop.1996.12.481&rft_dat=%3Cproquest_cross%3E78594511%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78594511&rft_id=info:pmid/8951684&rfr_iscdi=true